Provectus Biopharmaceuticals, Inc.
Headquarters Knoxville, TN
Financials
Prospectuses and Registrations
FORMNAMEDATE FILED
424B3Prospectus3/6/2017424B3Prospectus2/21/2017424B3Prospectus2/9/2017424B4Prospectus1/31/2017S-1/AGeneral form for registration of securities under the Securities Act of 19331/26/2017S-1/AGeneral form for registration of securities under the Securities Act of 19331/19/2017S-1/AGeneral form for registration of securities under the Securities Act of 193312/21/2016
Proxies
FORMNAMEDATE FILED
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material6/18/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material5/1/2025DEF 14AOther definitive proxy statements5/1/2025PRE 14AOther preliminary proxy statements4/18/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material6/20/2024DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material5/6/2024DEF 14AOther definitive proxy statements5/6/2024
News
FORMNAMEDATE FILED
8-KSubmission of Matters to a Vote of Security Holders6/20/20258-KRegulation FD Disclosure6/18/20258-KFinancial Statements and Exhibits4/16/20258-KEntry into a Material Definitive Agreement1/22/20258-KEntry into a Material Definitive Agreement12/26/20248-KNews Release12/11/20248-KFinancial Statements and Exhibits12/5/2024
Ownership
Others
FORMNAMEDATE FILED
DNotice of Exempt Offering of Securities7/17/2024DNotice of Exempt Offering of Securities10/28/2022DNotice of Exempt Offering of Securities8/30/202125-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities4/21/201725-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities4/21/2017EFFECTNotice of Effectiveness1/27/2017CORRESPCorrespondence1/27/2017